Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-08-17
1990-12-11
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514342, 514343, 544295, 544316, 544364, 544372, 546 20, 546208, 546209, 546280, 546281, 548136, 548171, 548187, 548246, 548302, 548336, 548374, 548538, 5482676, A61K 31445, C07D40112
Patent
active
049771671
ABSTRACT:
A compound of the formula: ##STR1## (wherein R is phenoxy optionally substituted by a halogen, methoxy, or methyl group, ##STR2## one of A and B is ##STR3## and the other is >CH.sub.2 : R.sup.1 is hydrogen or C.sub.1 -C.sub.5 alkyl; Z.sup.1 is phenyl, benzyl, or isoxazolyl each optionally substituted by a halogen, methoxy, or methyl group; Z.sup.2 is hydrogen, C.sub.1 -C.sub.5 alkyl, C.sub.2 -C.sub.5 alkenyl, or phenyl optionally mono-, di-, or tri-substituted by a halogen, methoxy, or methyl group; or Z.sup.1 and Z.sup.2 taken together with the adjacent nitrogen atom may form 5-membered heterocyclic group; Z.sup.3 is C.sub.1 -C.sub.5 hydroxyalkyl, di(C.sub.1 -C.sub.5 alkyl)sulfamoyl, 6-membered heterocyclic group, phenyl, benzyl, or phenylsulfonyl each phenyl moiety of the last three members being optionally substituted by a halogen, methoxy, or methyl group; Z.sup.4 is phenyl optionally substituted by a halogen, methoxy, or methyl group or 5- or 6-membered heterocyclic group which is optionally substituted by a halogen, methoxy, or methyl group and which can be optionally condensed with a benzene ring; Z.sup.5 is thienyl or phenyl each optionally substituted by a halogen, methoxy, or methyl group; Z.sup.6 is thienyl or phenyl each optionally substituted by a halogen, methoxy, or methyl group; m is an integer from 0 to 2; n is an integer from 2 to 3) or its pharmaceutical acceptable acid addition salt being useful as a drug for senile dementia, psychotropic, or antiamnesia agent is provided through several routes.
REFERENCES:
patent: 2829146 (1958-04-01), Beaver et al.
patent: 4118396 (1978-10-01), Pifferi et al.
patent: 4145347 (1979-03-01), L'Italien et al.
patent: 4369139 (1983-01-01), Kyburz et al.
patent: 4670456 (1987-06-01), Weber et al.
patent: 4791112 (1988-12-01), Bagley et al.
Chemical Abstracts, vol. 87, No. 17, p. 217, Abstract No. 87:128886g.
Chemical Abstracts, vol. 91, No. 4, p. 611, Abstract No. 91:39238n.
Chemical Abstracts, vol. 95, No. 19, p. 719, Abstract No: 95:168964c.
Eigyo Masami
Matsumura Hiromu
Matsushita Akira
Yano Toshisada
Raymond Richard L.
Shionogi & Co. Ltd.
Turnipseed James H.
LandOfFree
Carbamoylpyrolidone derivatives and drugs for senile dementia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carbamoylpyrolidone derivatives and drugs for senile dementia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carbamoylpyrolidone derivatives and drugs for senile dementia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-390498